MedTrace Logo

Population Pharmacokinetics of Metronidazole in Neonates

NCT04031183 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2020-07-28

No results posted yet for this study

Summary

The objective of NEOPOPI is to conduct a population pharmacokinetic study of metronidazole in neonates, in order to evaluate and optimize neonatal dose regimen.

There will be no change to the medication treatment received by participants. An opportunistic pharmacokinetic sampling approach will be followed: samples will be scavenged from blood or cerebrospinal fluid drawn for routine biochemical tests. In this way, no additional invasive tests will be needed.

Conditions

  • Emergencies

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Max Age
44 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-29
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031183 on ClinicalTrials.gov